Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging drug design strategies in anti-influenza drug discovery
Chuanfeng Liu, Lide Hu, Guanyu Dong, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 12, pp. 4715-4732
Open Access | Times Cited: 13

Showing 13 citing articles:

Function and therapeutic prospects of next-generation probiotic Akkermansia muciniphila in infectious diseases
Lifeng Li, Mingchao Li, Yihua Chen, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 15
Unveiling the ghost: machine learning’s impact on the landscape of virology
Sebastian Bowyer, David J. Allen, Nicholas Furnham
Journal of General Virology (2025) Vol. 106, Iss. 1
Closed Access
Advances in development of antiviral strategies against respiratory syncytial virus
Ge Yang, Guangyu Jiang, Jian–Dong Jiang, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Overview of host-directed antiviral targets for future research and drug development
Xiaoxia Gu, Mengzhu Zheng, Ya Gao, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Discovery and Development of VV116: A Novel Oral Nucleoside Anti‐SARS‐CoV‐2 Drug

(2025), pp. 389-410
Closed Access
Rational Design of Antiviral Therapeutics
Sneha Dokhale, Samiksha Garse, Shine Devarajan, et al.
(2024), pp. 423-443
Closed Access | Times Cited: 2
A protectin DX (PDX) analog with in vitro activity against influenza A(H1N1) viruses
Nicolas Fortin, Mathilde Hénaut, Nathalie Goyette, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 3
Closed Access | Times Cited: 1
Harnessing PROTACs to combat H5N1 influenza: A new frontier in viral destruction
Nobendu Mukerjee, Swastika Maitra, Dattatreya Mukherjee, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 9
Open Access | Times Cited: 1
SARS-CoV-2 Genotyping Highlights the Challenges in Spike Protein Drift Independent of Other Essential Proteins
Jeremy W. Prokop, Sheryl Alberta, Martin Witteveen‐Lane, et al.
Microorganisms (2024) Vol. 12, Iss. 9, pp. 1863-1863
Open Access
Viral Protein Dimerization Quality Control: A Design Strategy for a Potential Viral Inhibitor
Shaoqing Du, Xinyong Liu, Xueping Hu, et al.
Journal of Medicinal Chemistry (2024)
Closed Access
Comparative pathogenicity of influenza virus-induced pneumonia mouse model following intranasal and aerosolized intratracheal inoculation
Xiu-Yu Jin, Hui-Ying Yang, Guangyu Zhao, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access
Antiviral and antiretroviral prodrugs
L Pisano, Claudiu T. Supuran
Elsevier eBooks (2024), pp. 219-232
Closed Access
Unveiling Innovative anti-influenza Agents Through Modern Medicinal Chemistry Approaches (2019–2023 updates)
Chuanfeng Liu, Lide Hu, Huinan Jia, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 21, pp. 1915-1917
Closed Access
Page 1

Scroll to top